Cargando…

Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems

The aim was to explore the antimicrobial activity of a synthetic peptide (AMP38) and its synergy with imipenem against imipenem-resistant Pseudomonas aeruginosa. The main mechanism of imipenem resistance is the loss or alteration of protein OprD. Time-kill and minimal biofilm eradication concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudilla, Héctor, Fusté, Ester, Cajal, Yolanda, Rabanal, Francesc, Vinuesa, Teresa, Viñas, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273456/ https://www.ncbi.nlm.nih.gov/pubmed/27626405 http://dx.doi.org/10.3390/molecules21091223

Ejemplares similares

New and old tools to evaluate new antimicrobial peptides
por: Rudilla, Hector, et al.
Publicado: (2018)

Clinical Outcomes of Antipseudomonal vs. Non-Antipseudomonal Therapy in Patients with Osteomyelitis
por: Jansen, Jeffrey W, et al.
Publicado: (2017)

Clinical review: Balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use
por: Slama, Thomas G
Publicado: (2008)

Mortality in patients with carbapenem-resistant Pseudomonas aeruginosa with and without susceptibility to traditional antipseudomonal β-lactams
por: Howard-Anderson, Jessica, et al.
Publicado: (2021)

KDEON WK-11: A short antipseudomonal peptide with promising potential
por: Casciaro, Bruno, et al.
Publicado: (2022)

Relation between Resistance to Antipseudomonal β-Lactams and ampC and mexC Genes of Pseudomonas aeruginosa
por: Rezaei, Fatemeh, et al.
Publicado: (2016)

Free and Nanoencapsulated Tobramycin: Effects on Planktonic and Biofilm Forms of Pseudomonas
por: Sans-Serramitjana, Eulalia, et al.
Publicado: (2017)

Antipseudomonal β-Lactams Resistance in Iran
por: Rabiei, Mohammad Mahdi, et al.
Publicado: (2020)

Linker-Free Synthesis of Antimicrobial Peptides Using a Novel Cleavage Reagent: Characterisation of the Molecular and Ionic Composition by nanoESI-HR MS
por: Segovia, Roser, et al.
Publicado: (2023)

An evaluation of antipseudomonal dosing on the incidence of treatment failure
por: Hawkins, Brandon K, et al.
Publicado: (2021)

834. Clinical Outcomes with Carbapenem-Resistant Pseudomonas aeruginosa that Retain Susceptibility to Traditional Antipseudomonal β-lactams: Atlanta, 2016-2018
por: Howard-Anderson, Jessica, et al.
Publicado: (2020)

Antipseudomonal and Immunomodulatory Properties of Esc Peptides: Promising Features for Treatment of Chronic Infectious Diseases and Inflammation
por: Cappiello, Floriana, et al.
Publicado: (2021)

Quorum Quenching: A Potential Target for Antipseudomonal Therapy
por: Hemmati, Fatemeh, et al.
Publicado: (2020)

Native Pig Neutrophil Products: Insights into Their Antimicrobial Activity
por: Fernández-De La Cruz, Eric, et al.
Publicado: (2023)

A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity
por: Rabanal, Francesc, et al.
Publicado: (2015)

Unveiling the Membrane and Cell Wall Action of Antimicrobial Cyclic Lipopeptides: Modulation of the Spectrum of Activity
por: Segovia, Roser, et al.
Publicado: (2021)

Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy
por: Tennant, Sarah J., et al.
Publicado: (2015)

Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department
por: Angrill, Nuria, et al.
Publicado: (2020)

Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
por: Hong, Mai-Chi, et al.
Publicado: (2013)

Antipseudomonal Drug Exposure Associated with MDR Organisms in the Liver and Lung Transplant Population
por: Mulugeta, Surafel G, et al.
Publicado: (2017)

Evaluation of the Empiric use of Levofloxacin in Combination with Antipseudomonal Β-Lactams for the Treatment of Pneumonia
por: Bachna, Jon, et al.
Publicado: (2017)

Effects of photodynamic therapy on Enterococcus faecalis biofilms
por: López-Jiménez, L., et al.
Publicado: (2015)

Antipseudomonal Versus Narrow-Spectrum Agents for the Treatment of Community-Onset Intra-abdominal Infections
por: Worden, Lacy J, et al.
Publicado: (2021)

400 Beyond the Antibiogram: Using Monte Carlo Analysis to Optimize Institution-Specific Antipseudomonal Therapy
por: Tennant, Sarah, et al.
Publicado: (2014)

2175. In vitro Potency of Ceftolozane/Tazobactam and Other Antipseudomonal β-Lactams Against P. aeruginosa
por: Abuhussain, Safa Almarzoky, et al.
Publicado: (2018)

695. Antipseudomonal Versus Narrow-spectrum Agents for the Treatment of Community-onset Intra-abdominal Infections
por: Worden, Lacy, et al.
Publicado: (2021)

Hospital-level variation in the utilization of antipseudomonal antibiotics: A nationwide cross-sectional study at the VHA
por: Hasegawa, Shinya, et al.
Publicado: (2022)

The Art of War with Pseudomonas aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy
por: Avakh, Asiyeh, et al.
Publicado: (2023)

Effects of synthetic peptide RP557 and its origin, LL-37, on carbapenem-resistant Pseudomonas aeruginosa
por: Song, Yun-Qi, et al.
Publicado: (2023)

Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
por: Cui, Kaiyu, et al.
Publicado: (2022)

Synergistic Antibiofilm Activity between Synthetic Peptides and Ciprofloxacin against Staphylococcus aureus
por: Neto, Nilton A. S., et al.
Publicado: (2022)

1587. Comparative In Vitro Antipseudomonal Activity of Ceftolozane/Tazobactam Against Pseudomonas aeruginosa Isolates from Children with Cystic Fibrosis
por: Kanwar, Neena, et al.
Publicado: (2019)

Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa Isolates
por: Sikorski, Aaron, et al.
Publicado: (2021)

Impact of a syndrome-specific antibiotic stewardship intervention on antipseudomonal antibiotic use in inpatient diabetic foot infection management
por: McCreery, Randy J., et al.
Publicado: (2023)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
por: Ávila-Núñez, M., et al.
Publicado: (2023)

Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis
por: Tan, Xinmei, et al.
Publicado: (2021)

Piperacillin–Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?
por: Aslan, Abdullah Tarık, et al.
Publicado: (2022)

The Novel CarbaLux Test for Carbapenemases and Carbapenem Deactivating AmpC Beta-Lactamases
por: Pfaendler, Hans Rudolf, et al.
Publicado: (2020)

Association between duration of antipseudomonal beta-lactam therapy and Clostridioides difficile infections in monomicrobial Enterobacterales bloodstream infections at an academic medical center
por: Hawkins, Audry M., et al.
Publicado: (2022)

Atomic force microscopy visualization of injuries in Enterococcus faecalis surface caused by Er,Cr:YSGG and diode lasers
por: López-Jiménez, Lidia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nlcqbg2glh8b58c31mtdppcjb0